REGENERON

Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led for 35 years by physician-scientists, Regeneron's unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in Regeneron's laboratories. Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases... Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more... We are the only biopharma company founded and led by physician-scientists since the beginning, more than three decades ago. From our first days, science was and remains our..

Also known as: Regeneron CANADA, Regeneron France, Regeneron Germany, Regeneron GmbH, Regeneron India, Regeneron Italy, Regeneron Japan, Regeneron Netherlands, Regeneron Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regeneron Spain

Registration numbers: 23.06.0001 (W)

Primary location: Tarrytown United States